home / stock / avr / avr news

AVR News and Press, Anteris Technologies Global Corp.

Stock Information
Company Name: Anteris Technologies Global Corp.
Stock Symbol: AVR
Market: NASDAQ
Website: www.anteristech.com
Menu
AVR AVR Quote AVR Short AVR News AVR Articles AVR Message Board
Get AVR Alerts

News, Short Squeeze, Breakout and More Instantly...
AVR - Anteris Technologies Global reports FY results

2026-02-27 07:20:08 ET More on Anteris Technologies Global Corp. Anteris Technologies Global prices $200M public offering and concurrent $90M Medtronic placement Seeking Alpha’s Quant Rating on Anteris Technologies Global Corp. Historical earnings data for Ant...
AVR - Anteris Reports 2025 Financial Results and Provides Corporate Update

MINNEAPOLIS and BRISBANE, Australia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medic...

AVR - Anteris to Present at Healthcare Investor Conferences TD Cowen and Barclays

MINNEAPOLIS and BRISBANE, Australia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medica...

AVR - Buy Recommendation Issued On AVR By Lake Street

2026-01-23 09:15:07 ET Lake Street analyst issues BUY recommendation for AVR on January 23, 2026 01:57PM ET. The previous analyst recommendation was Buy. AVR was trading at $6.45 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ana...
AVR - Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises

MINNEAPOLIS and BRISBANE, Australia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ( Anteris or the Company ) (NASDAQ: AVR , ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healt...

AVR - Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock

MINNEAPOLIS and BRISBANE, Australia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“ Anteris ” or the “ Company ”) (NASDAQ: AVR , ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cu...

AVR - Anteris Technologies Global prices $200M public offering and concurrent $90M Medtronic placement

2026-01-21 01:10:21 ET Anteris Technologies Global ( AMEUF ) ( AVR ) announced the pricing of its public offering of 34,782,609 shares at $5.75 per share, to raise about $200 million from this offering, before deductions. ... Read the full arti...
AVR - Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering

MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“ Anteris ” or the “ Company ”) (NASDAQ: AVR , ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cu...

AVR - Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic

MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“ Anteris ” or the “ Company ”) (NASDAQ: AVR , ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cu...

AVR - Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves

MINNEAPOLIS and BRISBANE, Australia, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ( Anteris or the Company ) (NASDAQ: AVR, ASX: AVR) today released 30-day clinical outcomes for the DurAVR ® THV in one hundred severe aortic stenosis patients with small a...
Next 10